TREA

86873967 - DEVELOPMENT BY DESIGN

Follow

Information

  • Trademark
  • 86873967
  • Serial Number
    86873967
  • Registration Number
    5220043
  • Filing Date
    January 13, 2016
    9 years ago
  • Registration Date
    June 06, 2017
    7 years ago
  • Transaction Date
    July 16, 2024
    8 months ago
  • Status Date
    June 07, 2024
    10 months ago
  • Location Date
    June 07, 2024
    10 months ago
  • Status Code
    704
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DESAI, BRIN ANDERSON
  • Attorney Docket Number
    120776HVN002
    Attorney Name
    Mainak H. Mehta
  • Owners
Information
Mark Drawing Code
4
Mark Identification
DEVELOPMENT BY DESIGN
Case File Statements
  • GS0401: research and development of manufacturing processes for the pharmaceutical industry; research in the field of optimizing manufacturing processes for the pharmaceutical industry
  • GS0051: [ Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals ]
  • GS0011: [ Active chemical ingredients for use in the manufacture of pharmaceuticals ]
Case File Event Statements
  • 2/25/2016 - 9 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/16/2016 - 9 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/19/2016 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/18/2016 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/25/2016 - 9 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/25/2016 - 9 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/25/2016 - 8 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/25/2016 - 8 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/26/2016 - 8 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/25/2016 - 8 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/25/2016 - 8 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/25/2016 - 8 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/26/2016 - 8 years ago
    13 - SUBSEQUENT FINAL REFUSAL WRITTEN Type: CFRC
  • 9/26/2016 - 8 years ago
    14 - SUBSEQUENT FINAL EMAILED Type: GNSF
  • 9/26/2016 - 8 years ago
    15 - NOTIFICATION OF SUBSEQUENT FINAL EMAILED Type: GNS1
  • 3/23/2017 - 8 years ago
    16 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 3/27/2017 - 8 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/27/2017 - 8 years ago
    18 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 3/27/2017 - 8 years ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/27/2017 - 8 years ago
    20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/27/2017 - 8 years ago
    21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/27/2017 - 8 years ago
    22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/6/2017 - 7 years ago
    26 - REGISTERED-SUPPLEMENTAL REGISTER Type: R.SR
  • 3/27/2017 - 8 years ago
    23 - APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Type: CNTA
  • 4/25/2017 - 7 years ago
    24 - ASSIGNED TO LIE Type: ALIE
  • 5/4/2017 - 7 years ago
    25 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/6/2022 - 2 years ago
    27 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 8/8/2023 - a year ago
    28 - TEAS SECTION 8 RECEIVED Type: ES8R
  • 11/21/2023 - a year ago
    29 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 11/21/2023 - a year ago
    30 - POST REGISTRATION ACTION MAILED - SEC. 8 Type: PRA8
  • 5/21/2024 - 10 months ago
    31 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 6/7/2024 - 10 months ago
    33 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8
  • 6/7/2024 - 10 months ago
    32 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED Type: 8.PR